The Federal Reserve's favorite inflation gauge showed prices increased slightly in December 2024. Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial ...
Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million. The muted market ...
U.S. stock futures moved marginally higher on Thursday following the latest flurry of U.S. economic reports. Investors received the first reading on Q4 GDP. The data showed the U.S. economy expanded ...
Blackwell production has ramped up to 100%; there are plans for capacity expansion, including into the U.S., and the next-gen technology will soon be available. Rubin, the next iteration of NVIDIA’s ...
The Federal Reserve's favorite inflation gauge showed prices increased slightly in December 2024. Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial ...
U.S. stocks finished higher on Tuesday, as the S&P 500 and the Nasdaq Composite recovered most of their losses from the previous session after the sudden rise of Chinese AI startup DeepSeek sent ...
Some results have been hidden because they may be inaccessible to you